Back to mobile site

Merck KGaA to acquire Silence Therapeutics for $1.1B

October 19, 2026 8:00 AM EDT Send to a Friend
Merck KGaA, Darmstadt, Germany, has agreed to acquire Silence Therapeutics plc (Nasdaq: SLN), a London-based clinical-stage biotechnology company, in a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login